Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

567 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The development of decision limits for the implementation of the GH-2000 detection methodology using current commercial insulin-like growth factor-I and amino-terminal pro-peptide of type III collagen assays.
Erotokritou-Mulligan I, Guha N, Stow M, Bassett EE, Bartlett C, Cowan DA, Sönksen PH, Holt RI. Erotokritou-Mulligan I, et al. Among authors: bartlett c. Growth Horm IGF Res. 2012 Apr;22(2):53-8. doi: 10.1016/j.ghir.2011.12.005. Epub 2012 Feb 10. Growth Horm IGF Res. 2012. PMID: 22305721
The effects of a freeze-thaw cycle and pre-analytical storage temperature on the stability of insulin-like growth factor-I and pro-collagen type III N-terminal propeptide concentrations: Implications for the detection of growth hormone misuse in athletes.
Guha N, Erotokritou-Mulligan I, Bartlett C, Cowan DA, Bassett EE, Stow M, Sönksen PH, Holt RI. Guha N, et al. Among authors: bartlett c. Drug Test Anal. 2012 Jun;4(6):455-9. doi: 10.1002/dta.1339. Epub 2012 Apr 17. Drug Test Anal. 2012. PMID: 22511534
Biochemical markers of insulin-like growth factor-I misuse in athletes: the response of serum IGF-I, procollagen type III amino-terminal propeptide, and the GH-2000 score to the administration of rhIGF-I/rhIGF binding protein-3 complex.
Guha N, Erotokritou-Mulligan I, Bartlett C, Nevitt SP, Francis M, Bassett EE, Cowan DA, Sönksen PH, Holt RI. Guha N, et al. Among authors: bartlett c. J Clin Endocrinol Metab. 2014 Jun;99(6):2259-68. doi: 10.1210/jc.2013-3897. Epub 2014 Feb 25. J Clin Endocrinol Metab. 2014. PMID: 24606087 Clinical Trial.
The effect of sports injury on insulin-like growth factor-I and type 3 procollagen: implications for detection of growth hormone abuse in athletes.
Erotokritou-Mulligan I, Bassett EE, Bartlett C, Cowan D, McHugh C, Seah R, Curtis B, Wells V, Harrison K, Sönksen PH, Holt RI; GH-2004 Group. Erotokritou-Mulligan I, et al. Among authors: bartlett c. J Clin Endocrinol Metab. 2008 Jul;93(7):2760-3. doi: 10.1210/jc.2007-2801. Epub 2008 Apr 15. J Clin Endocrinol Metab. 2008. PMID: 18413420
567 results